03/04/2023Published by Fondazione Gianni Bonadonna at 03/04/2023Categories Events UncategorizedMetastatic site and survival in colorectal cancer treated with pembrolizumab
27/03/2023Published by Fondazione Gianni Bonadonna at 27/03/2023Categories Events UncategorizedThe ALPHABET study on breast cancer is enrolling patients
20/03/2023Published by Fondazione Gianni Bonadonna at 20/03/2023Categories Events UncategorizedDabrafenib and trametinib in anaplastic advanced thyroid cancer
13/03/2023Published by Fondazione Gianni Bonadonna at 13/03/2023Categories Events UncategorizedMediterranean diet could improve efficacy of immunotherapy in advanced melanoma
06/03/2023Published by Fondazione Gianni Bonadonna at 06/03/2023Categories Events UncategorizedOlaparib in BRCA-mutated, HER-2 negative metastatic breast cancer
27/02/2023Published by Fondazione Gianni Bonadonna at 27/02/2023Categories Events UncategorizedAvelumab added to chemotherapy in advanced or recurrent endometrial cancer
20/02/2023Published by Fondazione Gianni Bonadonna at 20/02/2023Categories Events UncategorizedTrastuzumab deruxtecan in advanced gastric tumors
13/02/2023Published by Fondazione Gianni Bonadonna at 13/02/2023Categories Events UncategorizedA young hematologist and researcher is awarded a Fellowship in the second edition of the Call dedicated to the memory of Gianni Bonadonna
06/02/2023Published by Fondazione Gianni Bonadonna at 06/02/2023Categories Events UncategorizedFederated learning to predicting chemotherapy response in triple-negative breast cancer
